These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11882597)

  • 21. Regulation of Blood Pressure, Appetite, and Glucose by Leptin After Inactivation of Insulin Receptor Substrate 2 Signaling in the Entire Brain or in Proopiomelanocortin Neurons.
    do Carmo JM; da Silva AA; Wang Z; Freeman NJ; Alsheik AJ; Adi A; Hall JE
    Hypertension; 2016 Feb; 67(2):378-86. PubMed ID: 26628674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation?
    Silva AA; Kuo JJ; Tallam LS; Liu J; Hall JE
    Hypertension; 2006 Feb; 47(2):259-64. PubMed ID: 16380516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term physiological hyperleptinemia decreases arterial blood pressure.
    Knight WD; Seth R; Boron J; Overton JM
    Regul Pept; 2009 Apr; 154(1-3):60-8. PubMed ID: 19323984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic central ghrelin infusion reduces blood pressure and heart rate despite increasing appetite and promoting weight gain in normotensive and hypertensive rats.
    Freeman JN; do Carmo JM; Adi AH; da Silva AA
    Peptides; 2013 Apr; 42():35-42. PubMed ID: 23416021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of dopamine receptor and adrenoceptor blockade on the hemoconcentrating and hypotensive actions of atrial natriuretic peptide.
    Valentin JP; Ribstein J; Nafrialdi N; Mimran A
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1142-7. PubMed ID: 9365827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pressor effect of the putative M1 muscarinic receptor agonist MCN-A-343 in the conscious rat.
    Martin JR
    Life Sci; 1996; 59(22):1839-52. PubMed ID: 8950281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure.
    Correia ML; Morgan DA; Sivitz WI; Mark AL; Haynes WG
    Hypertension; 2001 Mar; 37(3):936-42. PubMed ID: 11244021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation?
    Mitchell JL; Morgan DA; Correia ML; Mark AL; Sivitz WI; Haynes WG
    Hypertension; 2001 Nov; 38(5):1081-6. PubMed ID: 11711501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat.
    Monopoli A; Casati C; Lozza G; Forlani A; Ongini E
    J Pharmacol Exp Ther; 1998 Apr; 285(1):9-15. PubMed ID: 9535988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of protein tyrosine phosphatase 1b in proopiomelanocortin neurons reduces neurogenic control of blood pressure and protects mice from leptin- and sympatho-mediated hypertension.
    Bruder-Nascimento T; Butler BR; Herren DJ; Brands MW; Bence KK; Belin de Chantemèle EJ
    Pharmacol Res; 2015 Dec; 102():235-44. PubMed ID: 26523876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.
    Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Anand Swarup KR; Johns EJ
    Auton Autacoid Pharmacol; 2011; 31(1-2):13-20. PubMed ID: 21166975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The action of adrenergic agonists and antagonists on kidney function and arterial pressure depending on the mineral component of the diet].
    Shtrygol' SIu; Branchevskiĭ LL
    Eksp Klin Farmakol; 1995; 58(5):31-3. PubMed ID: 8704586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central leptin infusion attenuates the cardiovascular and metabolic effects of fasting in rats.
    Overton JM; Williams TD; Chambers JB; Rashotte ME
    Hypertension; 2001 Feb; 37(2 Pt 2):663-9. PubMed ID: 11230353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sustained adrenergic receptors stimulation and blockade on lactate threshold in rats.
    Zarzeczny R; Langfort J; Pilis W; Nazar K; Kaciuba-Uścilko H; Porta S
    J Sports Med Phys Fitness; 2001 Sep; 41(3):324-9. PubMed ID: 11533562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling.
    da Silva AA; Spradley FT; Granger JP; Hall JE; do Carmo JM
    J Neurophysiol; 2015 Apr; 113(7):2786-91. PubMed ID: 25717164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of adrenergic, cholinergic and ganglionic blockade on acute depressor responses to metformin in spontaneously hypertensive rats.
    Muntzel MS; Abe A; Petersen JS
    J Pharmacol Exp Ther; 1997 May; 281(2):618-23. PubMed ID: 9152364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products.
    Dunbar JC; Lu H
    Brain Res Bull; 1999 Oct; 50(3):215-21. PubMed ID: 10566984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central adrenergic receptor control of renal function in conscious hypertensive rats.
    Koepke JP; DiBona GF
    Hypertension; 1986 Feb; 8(2):133-41. PubMed ID: 3002980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of oestrogen.
    Shi Z; Brooks VL
    J Physiol; 2015 Apr; 593(7):1633-47. PubMed ID: 25398524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic intravenous glucose infusion causes moderate hypertension in rats.
    Brands MW; Fitzgerald SM
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):99-102. PubMed ID: 10678278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.